SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-20-001092
Filing Date
2020-12-10
Accepted
2020-12-10 08:34:10
Documents
8
Period of Report
2020-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm 8-K 38343
2 CERTIFICATE OF AMENDMENT TO THE THIRD AMENDED AND RESTATED CERTIFICATE OF INCORP htbx_ex3z1.htm EX-3.1 9672
3 AMENDED LICENSE AGREEMENT (UMI-176) htbx_ex10z1.htm EX-10.1 9720
4 AMENDED LICENSE AGREEMENT (UMSS-114) htbx_ex10z2.htm EX-10.2 10017
5 AMENDED LICENSE AGREEMENT (D-107) htbx_ex10z3.htm EX-10.3 9810
6 AMENDED LICENSE AGREEMENT (UMSS-114A) htbx_ex10z4.htm EX-10.4 9908
7 PRESS RELEASE htbx_ex99z1.htm EX-99.1 10294
8 GRAPHIC htbx_ex99z1001.jpg GRAPHIC 24604
  Complete submission text file 0001553350-20-001092.txt   133126
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 201379561
SIC: 2834 Pharmaceutical Preparations